Trial Profile
Nebivolol for the Relief of Microvascular Angina in Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Syndrome X
- Focus Therapeutic Use
- Acronyms NIRVANA
- 18 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2015 Planned End Date changed from 1 Dec 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
- 02 Jun 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.